Skip to main content

ED Visit Rate 72.2 Per 1,000 Adults With Diabetes in 2020 to 2021

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 21, 2023.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Dec. 20, 2023 -- In 2020 to 2021, the emergency department visit rate was 72.2 visits per 1,000 adults with diabetes, with the rate increasing with age, according to a December data brief published by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics.

Loredana Santo, M.D., M.P.H., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues used data from the National Hospital Ambulatory Medical Care Survey to describe emergency department visits made by adults with diabetes.

The researchers found that the emergency department visit rate by adults with diabetes was 72.2 per 1,000 adults in 2020 to 2021, and the rate increased with age. The highest emergency department visit rates by adults with diabetes were seen among Black non-Hispanic people (136.6 per 1,000 adults per year) and were higher among White non-Hispanic than Hispanic individuals (69.9 versus 52.3 visits per 1,000 adults per year). For adults with diabetes and two to four chronic conditions, the emergency department visit rate was 541.4 per 1,000 adults per year in 2020 to 2021 and increased with age. For adults with diabetes, there was an increase seen in emergency department visit rates from 48.6 to 74.9 visits per 1,000 adults in 2012 and 2021, respectively.

"From 2012 through 2021, emergency department visit rates among all adults with diabetes increased, as well as among adults age 45 and older," the authors write. "Among adults ages 18 to 44, emergency department visit rates increased during 2012 to 2016 and then remained stable during 2016 to 2021."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Small but Important Differences Seen Between Rosuvastatin, Atorvastatin

WEDNESDAY, Oct. 30, 2024 -- There are small but important differences in risk for some clinical outcomes associated with rosuvastatin and atorvastatin, according to a study...

AI Can Help ID Patients With Diabetes at Highest Risk for Cardiomyopathy

WEDNESDAY, Oct. 30, 2024 -- Machine learning can help identify individuals with diabetes at high risk for diabetic cardiomyopathy (DbCM), according to a study published online...

2010 to 2023 Saw Increase in GLP-1 RA, SGLT2 Inhibitor Use in Type 1 Diabetes

MONDAY, Oct. 28, 2024 -- From 2010 to 2023, there was an increase in prescribing of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) and sodium glucose cotransporter 2...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.